ÂÜÀòÂÒÂ×

Yan Zhou, M.D., Ph.D. has a diverse work experience in various positions. They are currently serving as the Director of Business Development at Shanghai Medicilon Inc. since August 2022. Prior to that, they worked as a Business Development Manager at Biocytogen from January 2022 to August 2022.

In 2021, Yan Zhou worked at SQZ Biotechnologies as a Scientist II of Translational Medicine. Their responsibilities included internal assay development for clinical trial cancer patients' biomarker detection and technology transfer to an external vendor.

From 2015 to 2021, Yan Zhou served as a Postdoctoral Research Fellow at Harvard Medical School. Their contributions involved leading a multidisciplinary research project to identify CD8+ T cell antigens for L. monocytogenes and optimizing an antigen identification screening platform. They also worked as a Visiting Scholar during this time, conducting experiments to monitor immunosuppression and exploring interactions between intestinal commensals and neural-immune signals.

Prior to their research fellowship at Harvard, Yan Zhou worked as the Clinical Laboratory Lead at Shanghai Chest Hospital Affiliated to Shanghai Jiao Tong University from 2011 to 2015. In this role, they were responsible for establishing a tuberculosis IFN-¦Ã ELISPOT detection system and leading a team to study therapeutic strategies against bacterial meningitis.

Overall, Yan Zhou has a strong background in biomedical research, business development, and clinical laboratory management.

Yan Zhou, M.D.,Ph.D. pursued a Doctor of Medicine degree in Medicine at Dalian Medical University from 2001 to 2006. Afterwards, they went on to pursue a Doctor of Philosophy degree in Microbiology & Immunology at Shanghai Jiao Tong University, completing their studies in 2011.